Concepedia
6
Publications
162
Citations
H-Index
2006
Active since
Affiliations
Allergan (United States)(Current)
University College London
Allergan (United Kingdom)
Sanofi (United States)
Dmitry Gultyaev is an author at Allergan (United States).
Publications per year
2006–2021
Development and Validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) Model
Elvira Mueller, Stefanie Maxion‐Bergemann, Dmitry Gultyaev et al. · Diabetes Technology & Therapeutics · 2006 · 56 citations
Cost–effectiveness of overactive bladder treatments: from the US payer perspective
Brian Murray, Sam Hessami, Dmitry Gultyaev et al. · Journal of Comparative Effectiveness Research · 2018 · 35 citations · Full text
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser et al. · Journal of health economics and outcomes research · 2021 · 26 citations · Full text
Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population
Jie Meng, Roman Casciano, Yi‐Chien Lee et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 20 citations · Full text
OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
Nick Freemantle, Kristin Khalaf, C. Loveman et al. · The European Journal of Health Economics · 2015 · 14 citations · Full text
Rows per page
1–5 of 6